Sort by
Keyphrases
Annual Screening
20%
Benefit-harm
20%
Cancer Incidence
20%
CINAHL
20%
Cochrane Library
20%
Cochrane Review
20%
Colonoscopy
40%
Colorectal Adenoma
20%
Colorectal Cancer
40%
Colorectal Cancer Mortality
100%
Colorectal Cancer Prevention
20%
Colorectal Cancer Risk
20%
Combined Outcome
20%
Early Treatment
20%
Embase
20%
False-negative Results
20%
False-positive Results
20%
Fecal Occult Blood Test
100%
Financial Cost
20%
Fixed Effects Model
20%
Flexible Sigmoidoscopy
20%
Guaiacol
40%
Harmful Effects
20%
Hemoccult
100%
Heterogeneous Treatment Effects
20%
Human Cost
20%
In Cancer
20%
Intention to Screen
20%
MEDLINE
20%
Minimal Invasive Surgery
20%
Minnesota
20%
Nottingham
20%
One-round
20%
Population Screening
40%
Potential Consequences
20%
Principal Investigator
20%
Psychosocial Consequences
20%
Random Effects Model
20%
Randomized Controlled Trial
40%
Randomized Trial
20%
Reduced Mortality
20%
Relative Risk
40%
Relative Risk Reduction
40%
Risk Difference
20%
Screening Attendance
20%
Screening for Colorectal Cancer
100%
Screening Test
20%
Search Strategy
20%
Selection Criteria
20%
Western World
20%
Nursing and Health Professions
Attributable Risk
9%
Cancer Incidence
9%
Cancer Mortality
45%
CINAHL
9%
Cochrane Library
9%
Colonoscopy
18%
Colorectal Adenoma
9%
Colorectal Carcinoma
100%
Data Processing
18%
Diseases
9%
Embase
9%
False Negative Result
9%
False Positive Result
9%
Guaiac
18%
Malignant Neoplasm
9%
Mass Screening
9%
Medline
9%
Morbidity
9%
Occult Blood
100%
Occult Blood Test
100%
Screening Test
9%
Sigmoidoscopy
9%
Medicine and Dentistry
Attributable Risk
9%
Cancer Incidence
9%
Cancer Mortality
45%
Colonoscopy
18%
Colorectal Adenoma
9%
Colorectal Carcinoma
100%
Diseases
9%
False Negative Result
9%
False Positive Result
9%
Guaiacum
18%
Health Care Cost
9%
Invasive Surgery
9%
Malignant Neoplasm
9%
Mass Screening
9%
Morbidity
9%
Occult Blood Test
100%
Overdiagnosis
9%
Random Effects Model
9%
Randomized Controlled Trial
18%
Relative Risk Reduction
18%
Screening Test
9%
Sigmoidoscopy
9%